On average, there was no significant regain at four weeks versus controls, indicating early weight loss was largely maintained at that point
I am encouraged that theres a new avenue for therapy, and as these medications are developed and put into practice, says Peters, I think well be able to successfully identify who should be using them, who will be a good responder to the intervention, and who might need continued treatment. According to Malhotra, the bottom line is this: Diet, exercise, and sleep are the three pillars of health
Common Side Effects: Injection-site reactions: Mild redness, itching, pain, or bruising at injection area [9]
Final thoughts Cagrilintide and semaglutide represent the next evolution in medical weight loss through dual-pathway appetite suppression and metabolic optimization
Whether you are curious about starting a GLP-1 program or looking for ways to support your current progress, expert guidance is essential